Search results
Found 259 matches for
Protein test could lead to earlier and better diagnosis of Parkinson’s
Clinical Neurology Research
13 December 2021
Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.
Nine new Professors
Award Research
8 December 2021
Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.
Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize
Clinical Neurology Coronavirus Research
19 November 2021
In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.
New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
Clinical Neurology Research
3 November 2021
Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
Major research network to investigate body clock and stroke
Ophthalmology Research SCNi
27 October 2021
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
COVID-19 infection has greater risk than vaccines of causing very rare neurological events
Clinical Neurology Coronavirus Research
27 October 2021
Research reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
Mapping uncharted networks in the progression of Parkinson’s
Clinical Neurology MRC BNDU Research
26 October 2021
A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
New genetic diagnosis technology for eye disease receives major funding award
Ophthalmology Research
12 October 2021
Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.
Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd
Award Clinical Neurology Research
8 October 2021
Mapping brain network activity from structural connectivity using deep learning
Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness
Award Clinical Neurology Research
30 September 2021
Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.
How our dreams changed during the COVID-19 pandemic
Ophthalmology Research SCNi
29 September 2021
This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.
New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle
Ophthalmology Research
21 September 2021
A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.
Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis
Clinical Neurology Research
17 September 2021
Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.
International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic
Coronavirus Ophthalmology Research SCNi
10 September 2021
Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.
Alexander Davies wins top UKRI Future Leaders Fellowship
Award Clinical Neurology Research
8 September 2021
Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme
New study on link between autoimmunity and pain
Clinical Neurology Research
7 September 2021
Patients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.
Researchers identify distinct immunological mechanisms in early and late onset myasthenia gravis
Clinical Neurology Research
22 July 2021
John Jacob wins clinical academic research partnership for brain cancer project
Clinical Neurology Research
22 June 2021
The Medical Research Council awarded Dr John Jacob upwards of £200,000 to fund a project on brain cancer modelling.
A stem cell-based model offers new insights into the mechanisms of neuronal loss in Parkinson’s disease
Clinical Neurology Research
21 June 2021